• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MPRI SPRINT QUATTRO SECURE MRI SURESCAN; PERMANENT DEFIBRILLATOR ELECTRODES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MPRI SPRINT QUATTRO SECURE MRI SURESCAN; PERMANENT DEFIBRILLATOR ELECTRODES Back to Search Results
Model Number 6947M55
Device Problems Pacing Problem (1439); Under-Sensing (1661)
Patient Problems Cardiac Arrest (1762); Low Blood Pressure/ Hypotension (1914)
Event Date 02/09/2024
Event Type  Injury  
Event Description
It was reported that the patient experienced ventricular tachycardia (vt) arrest, hypotension, and required external cardioversion.The patient did not receive a shock for the vt arrest because vt and fast ventricular tachycardia (fvt) therapies and monitoring were not programmed on.The arrythmia was below the detection limit for the programmed ventricular fibrillation (vf) therapies.The patient also received possible inappropriate shocks for supra ventricular tachycardia (svt) that was detected as vf by the cardiac resynchronization therapy defibrillator (crt-d).There was right atrial (ra) lead and right ventricular (rv) lead undersensing noted that resulted in inappropriate pacing and possible delay in detection.The crt-d, ra lead, and rv lead remain in use. no further patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPRINT QUATTRO SECURE MRI SURESCAN
Type of Device
PERMANENT DEFIBRILLATOR ELECTRODES
Manufacturer (Section D)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer (Section G)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer Contact
paula bixby
8200 coral sea st ne
mounds view, MN 55112
7635055378
MDR Report Key18809296
MDR Text Key336579083
Report Number2649622-2024-05791
Device Sequence Number1
Product Code NVY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P920015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/19/2024
Device Model Number6947M55
Device Catalogue Number6947M55
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/11/2024
Initial Date FDA Received02/29/2024
Date Device Manufactured06/20/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DTPB2QQ CRT-D, 459888 LEAD, 5076-45 LEAD
Patient Outcome(s) Required Intervention; Life Threatening;
Patient Age72 YR
Patient SexFemale
Patient Weight54 KG
-
-